Skip to main content
. Author manuscript; available in PMC: 2016 Aug 1.
Published in final edited form as: Lancet HIV. 2015 Dec 17;3(2):e76–e84. doi: 10.1016/S2352-3018(15)00242-8

Table 3.

Association between clinical decision support system alerts and appropriate action on treatment

Unadjusted odds ratio (95% CI) p value Adjusted odds ratio (95% CI) p value
Site status

Control 1   ·· 1   ··
Intervention 3.22 (1.02–10.22)   0.047 3.18 (1.02–9.87)   0.05

Age group (years)

<15 0.90 (0.74–1.08)   0.25 0.97 (0.78–1.21)   0.81
15–24 1.25 (0.91–1.74)   0.17 1.38 (1.24–1.53) <0.0001
25–49 1.32 (1.18–1.46) <0.0001 1.47 (1.08–1.99)   0.013
≥50 1   ·· 1   ··

Sex

Male 1.11 (1.04–1.19)   0.0016 1.16 (1.09–1.24) <0.0001
Female 1   ·· 1   ··

Marital status

Married 1.21 (0.98–1.51)   0.077 ··   ··
Divorced or separated 1.31 (1.14–1.52)   0.0003 ··   ··
Widow 1   ·· ··   ··
Single 0.93 (0.84–1.03)   0.18 ··   ··

WHO stage

I 1   ·· 1   ··
II 1.67 (1.34–2.09) <0.0001 1.62 (1.58–1.67) <0.0001
III 1.68 (1.57–1.80) <0.0001 1.64 (1.30–2.06) <0.0001
IV 1.47 (0.91–2.40)   0.12 1.37 (0.89–2.12)   0.15

Baseline CD4 category (cells per μL)

<350 3.27 (2.87–3.73) <0.0001 ··   ··
350–500 2.85 (1.69–4.82) <0.0001 ··   ··
>500 1   ·· ··   ··

Transfer out

No 1.25 (0.79–1.97)   0.34 ··   ··
Yes 1   ·· ··   ··

First-line regimen

Nevirapine 1.85 (1.37–2.52) <0.0001 ··   ··
Efavirenz 1.41 (0.89–2.22)   0.14 ··   ··

ART adherence

Satisfactory 1.59 (0.67–3.79)   0.29 ··   ··
Unsatisfactory 1   ·· ··   ··

ART=antiretroviral therapy.